Circulating Tumor Markers for High Grade Glioma

Status: Completed
Location: See location...
Study Type: Observational
SUMMARY

The purpose of this study is to identify and quantify circulating tumor markers, which are associated with the presence of tumors. The current imaging available does not allow specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or swelling of the tumor after treatment before it shrinks). Our hope is that CTCs will provide a more accurate description of tumor state for high grade glioma patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: No
View:

• Patients with biopsy-proven high grade glioma who are undergoing definitive radiotherapy as a part of their treatment regimen or patients with radiographic appearance of high grade glioma

• Age 18 or older

• Signed informed consent

Locations
United States
Pennsylvania
Abramson Cancer Center of the University of Pennsylvania
Philadelphia
Time Frame
Start Date: April 2013
Completion Date: April 2020
Participants
Target number of participants: 30
Sponsors
Leads: Abramson Cancer Center of the University of Pennsylvania

This content was sourced from clinicaltrials.gov